# The Efficacy and Safety of Flurbiprofen Chip Versus Chlorhexidine Chip (Periochip®) in Therapy of Adult Chronic Periodontitis

> **NCT01040286** · PHASE2 · COMPLETED · sponsor: **Dexcel Pharma Technologies Ltd.**

## Conditions studied

- Periodontitis

## Interventions

- **DRUG:** Flurbiprofen
- **DRUG:** Chlorhexidine

## Key facts

- **NCT ID:** NCT01040286
- **Lead sponsor:** Dexcel Pharma Technologies Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** —
- **Final completion:** 2010-06
- **Target enrollment:** — (—)
- **Last updated:** 2010-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01040286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01040286, "The Efficacy and Safety of Flurbiprofen Chip Versus Chlorhexidine Chip (Periochip®) in Therapy of Adult Chronic Periodontitis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01040286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*